Oncology Today with Dr Neil Love

348 Épisodes

1. Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

   Publié: 20/05/2024
2. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

   Publié: 13/05/2024
3. Virtual Case Library: Metastatic Triple-Negative Breast Cancer

   Publié: 08/05/2024
4. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

   Publié: 06/05/2024
5. Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

   Publié: 03/05/2024
6. Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

   Publié: 01/05/2024
7. Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

   Publié: 26/04/2024
8. Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

   Publié: 24/04/2024
9. Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

   Publié: 23/04/2024
10. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

    Publié: 15/04/2024
11. Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

    Publié: 12/04/2024
12. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

    Publié: 05/04/2024
13. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

    Publié: 05/04/2024
14. The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

    Publié: 03/04/2024
15. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

    Publié: 27/03/2024
16. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

    Publié: 26/03/2024
17. Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

    Publié: 25/03/2024
18. Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

    Publié: 21/03/2024
19. Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

    Publié: 19/03/2024
20. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

    Publié: 15/03/2024